Cost-effectiveness model of Palivizumab in The Netherlands

被引:0
|
作者
Nuijten, MJ
Lebmeier, M
Daalderop, P
Wittenberg, W
机构
[1] Erasmus Univ, Jisp, AL, Netherlands
[2] Univ Sheffield, Sheffield, S Yorkshire, England
[3] Abbott BV, Hoofddorp, Netherlands
[4] Dept Hlth Econ & Outcomes Res, Ludwigshafen, Germany
关键词
D O I
10.1016/S1098-3015(10)67298-1
中图分类号
F [经济];
学科分类号
02 ;
摘要
引用
收藏
页码:A52 / A52
页数:1
相关论文
共 50 条
  • [21] Methodological Concerns Regarding Cost-effectiveness Analysis of Palivizumab in Florida Medicaid
    Mahadevia, Parthiv J.
    Makari, Doris
    Masaquel, Anthony
    ARCHIVES OF PEDIATRICS & ADOLESCENT MEDICINE, 2012, 166 (10): : 968 - 969
  • [22] Cost-effectiveness of pertussis booster vaccination in the Netherlands
    Rozenbaum, Mark H.
    De Cao, Elisabetta
    Postma, Maarten J.
    VACCINE, 2012, 30 (50) : 7327 - 7331
  • [23] COST-EFFECTIVENESS OF DIAGNOSING AXIAL SPONDYLOARTHRITIS IN THE NETHERLANDS
    Webers, C.
    Grimm, S.
    Van Tubergen, A.
    Van Gaalen, F. A.
    Van der Heijde, D.
    Joore, M.
    Boonen, A.
    ANNALS OF THE RHEUMATIC DISEASES, 2020, 79 : 510 - 511
  • [24] Cost-effectiveness of atorvastatin compared to simvastatin in the Netherlands
    Severens, JL
    Prins, MH
    Monteban, HC
    VALUE IN HEALTH, 2003, 6 (06) : 671 - 671
  • [25] Cost-effectiveness of nonavalent HPV vaccination in the Netherlands
    Palmer, Cody
    Dolk, Christiaan
    Sabale, Ugne
    Wang, Wei
    Saxena, Kunal
    EXPERT REVIEW OF VACCINES, 2024, 23 (01) : 312 - 323
  • [26] COST-EFFECTIVENESS OF MENINSOCOCCAL B VACCINATION IN THE NETHERLANDS
    Zeevat, F.
    Joost, S.
    Westra, T. A.
    Wilschut, J. C.
    van Sorge, N.
    Boersma, C.
    Postma, M. J.
    VALUE IN HEALTH, 2022, 25 (12) : S177 - S177
  • [27] COST-EFFECTIVENESS OF INFANT PNEUMOCOCCAL VACCINATION IN THE NETHERLANDS
    Vemer, P.
    Postma, M. J.
    VALUE IN HEALTH, 2013, 16 (07) : A334 - A334
  • [28] Cost-effectiveness of fosavancet in the treatment of osteoporosis in the Netherlands
    Jansen, J. P.
    Shavit, O.
    Bergman, G.
    Sen, S. S.
    OSTEOPOROSIS INTERNATIONAL, 2006, 17 : S259 - S259
  • [29] Cost-Effectiveness of Pediatric Influenza Vaccination in The Netherlands
    de Boer, Pieter T.
    Nagy, Lisa
    Dolk, Franklin C. K.
    Wilschut, Jan C.
    Pitman, Richard
    Postma, Maarten J.
    VALUE IN HEALTH, 2021, 24 (01) : 19 - 31
  • [30] Palivizumab and the importance of cost effectiveness
    Teale, Alison
    Deshpande, Sanjeev
    Burls, Amanda
    BMJ-BRITISH MEDICAL JOURNAL, 2009, 338